Based on The NAMSAL Study the Who Amends Its Recommendations on HIV

The first results of the NAMSAL (New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-income countries)  study, carried out by Swiss, French and Cameroonian teams, allowed the World Health Organization (WHO) to review its recommendations for the treatment of AIDS in order to better adapt them to the most diverse contexts. Until recently, WHO recommended two drugs – Dolutegravir and Efavirenz – for the treatment of HIV infection. However, these two treatments have never been compared under conditions commonly found in countries with a high HIV prevalence. The NAMSAL study carried out jointly by the University of Geneva (UNIGE) … Continue reading Based on The NAMSAL Study the Who Amends Its Recommendations on HIV